Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Fluorescein Angiography
NCT05664555Phase 4Completed
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Feb 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fluorescein sodium 10% injection in retinal diseases (RD), sponsored by Seoul National University Bundang Hospital. Started Feb 2023; status: completed.
02
Drugs
fluorescein sodium 10% injection
03
Conditions
retinal diseases (RD)
Beyond the preview
Go deeper on NCT05664555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05664555.